½ÃÀ庸°í¼­
»óǰÄÚµå
1617752

°³ÀÎ ½Äº° ½ÃÀå : Á¦Ç°º°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Human Identification Market by Product (Consumables, Instruments, Software), Technology (Capillary Electrophoresis, Microarrays, Next-generation Sequencing), Application, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 188 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

°³ÀÎ ½Äº° ½ÃÀåÀº 2023³â 7¾ï 6,945¸¸ ´Þ·¯·Î Æò°¡µÇ°í 2024³â¿¡´Â 8¾ï 4,101¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¬Æò±Õ 9.71% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 14¾ï 7,289¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°³ÀÎ ½Äº° ±â¼úÀÇ ¹üÀ§¿Í Á¤ÀÇ¿¡´Â º¸¾È ¹× ºñÁî´Ï½º ¿ëµµ·Î °³ÀÎÀÇ ½Å¿øÀ» È®ÀÎÇÏ´Â ´Ù¾çÇÑ ¹æ¹ýÀÌ Æ÷ÇԵ˴ϴÙ. ¿©±â¿¡´Â Áö¹® ÀνÄ, ȫä ¹× ¾ó±¼ ½ºÄµ, À½¼º ÀνÄ, DNA ºÐ¼®°ú °°Àº »ýüÀÎ½Ä ½Ã½ºÅÛÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ±â¼úÀÇ Çʿ伺Àº ¹ýÁýÇà±â°ü, ÀÇ·á, ÀºÇà, ±¹°æ °ü¸® ¹× ±âŸ »ê¾÷¿¡¼­ º¸¾È, ½Å¿ø »ç±â ¹× È¿À²ÀûÀΠ󸮿¡ ´ëÇÑ ¿ì·Á°¡ Áõ°¡ÇÔ¿¡ µû¶ó »ý°Ü³µ½À´Ï´Ù. °³ÀÎ ½Äº° ±â¼úÀº ÃâÀÔ ÅëÁ¦, °Å·¡ º¸¾È, ÀÎÁõ ÇÁ·Î¼¼½º, °³ÀÎÈ­µÈ °í°´ °æÇè Á¦°ø µî¿¡ Àû¿ëµÇ¸ç, ÃÖÁ¾ ¿ëµµ´Â Á¤ºÎ, »ó¾÷ ¹× °³ÀÎ ¿µ¿ª¿¡ °ÉÃÄ ´Ù¾çÇÕ´Ï´Ù. ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ¸Ó½Å·¯´×, ÀΰøÁö´É, ID È®ÀÎ °ü¸® ¼Ö·ç¼ÇÀÇ ±Þ¼ÓÇÑ ¹ßÀüÀ¸·Î Á¤È®µµ Çâ»ó, ºñ¿ë Àý°¨, »ç¿ëÀÚ ÆíÀǼº Çâ»ó µîÀÌ ²ÅÈü´Ï´Ù. »ýüÀÎ½Ä ½Ã½ºÅÛÀÌ ÅëÇÕµÈ ¸ð¹ÙÀÏ ±â±âÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí, ´Ù¾çÇÑ ºÎ¹®¿¡¼­ µðÁöÅÐÈ­°¡ ÁøÇàµÇ¸é¼­ ½ÃÀå È®´ë¿¡ Å« ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ[2023] 7¾ï 6,945¸¸ ´Þ·¯
ÃßÁ¤ ¿¬µµ[2024] 8¾ï 4,101¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2030] 14¾ï 7,289¸¸ ´Þ·¯
CAGR(%) 9.71%

´Ù¾çÇÑ »ýüÀÎ½Ä µ¥ÀÌÅ͸¦ °áÇÕÇÏ¿© ´õ ³ôÀº Á¤È®µµ¸¦ ´Þ¼ºÇÏ°í ½ºÇªÇÎÀÇ À§ÇèÀ» ÁÙÀ̱â À§ÇØ º¸´Ù °­·ÂÇÑ ¸ÖƼ¸ð´Þ ½Äº° ½Ã½ºÅÛÀ» °³¹ßÇÒ ¼ö ÀÖ´Â ÀáÀçÀû ±âȸ°¡ ÀÖ½À´Ï´Ù. ½ÅÈï±¹ ½ÃÀåÀº ¹Ì°³Ã´ ½ÃÀåÀ¸·Î, º¸¾ÈÀ» °­È­Çϱâ À§ÇÑ Ã·´Ü ½Äº° Ç÷§Æû¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±âȸ¸¦ Æ÷ÂøÇϱâ À§ÇÑ ±ÇÀå»çÇ×À¸·Î´Â º¸´Ù ¾ÈÀüÇÏ°í ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀ» Çõ½ÅÇϱâ À§ÇÑ R&D ÅõÀÚ, ½ÃÀå ÁøÀÔÀ» À§ÇÑ Àü·«Àû ÆÄÆ®³Ê½Ê Çü¼º, ¼ÒºñÀÚÀÇ ½Å·Ú¸¦ ¾ò±â À§ÇÑ °³ÀÎÁ¤º¸ º¸È£ ±ÔÁ¤ Áؼö¿¡ ÁýÁßÇÏ´Â °Í µîÀÌ ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº Ãʱâ ÅõÀÚ ºñ¿ë, ÇÁ¶óÀ̹ö½Ã Ä§ÇØ ¿ì·Á, ±â¼ú ³ëÈÄÈ­ °¡´É¼º µîÀÌ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇÁ¶óÀ̹ö½Ã Ä§ÇØ¸¦ ¿ì·ÁÇÏ´Â °í°´ÀÇ ÀúÇ×°ú À±¸®Àû ¹®Á¦µµ µµÀü °úÁ¦ÀÔ´Ï´Ù.

Ç÷§Æû °£ ½Ã½ºÅÛ »óÈ£¿î¿ë¼ºÀ» °­È­ÇÏ°í º¹ÀâÇÑ ½ÇÁ¦ ȯ°æ¿¡ ´ëÇÑ ½Äº° ±â¼úÀÇ °ß°í¼ºÀ» Çâ»ó½ÃŰ´Â µ¥ ÁßÁ¡À» µÎ¸é Çõ½ÅÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. °æÀïÀûÀÎ °¡°Ý Àü·«À» Àå·ÁÇÏ°í »ç¿ëÀÚ °æÇèÀ» °³¼±ÇÔÀ¸·Î½á º¸´Ù ±¤¹üÀ§ÇÑ ½ÃÀå µµÀÔÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀº ¿ªµ¿ÀûÀÌ°í °æÀïÀÌ Ä¡¿­Çϸç, ¼ö¸¹Àº ÁøÀÔÀÚµéÀÌ ±â¼ú Çõ½ÅÀ» À§ÇØ ³ë·ÂÇϰí Àֱ⠶§¹®¿¡ ¼±µÎ¸¦ À¯ÁöÇϱâ À§Çؼ­´Â Áö¼ÓÀûÀÎ ÀûÀÀ°ú ¹Îø¼ºÀÌ ÇÊ¿äÇÏ´Ù´Â Á¡ÀÌ °­Á¶µÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â °³ÀÎ ½Äº° ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

°³ÀÎ ½Äº° ½ÃÀåÀº ¼ö¿ä¿Í °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ» ÅëÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«Àû ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ÃËÁø¿äÀÎ
    • DNA ½ÃÄö½Ì ¹× »ýüÀÎ½Ä ±â¼ú Çõ½Å
    • ¹üÁË ¹ß»ý·ü Áõ°¡¿¡ µû¸¥ °­·ÂÇÑ ½Äº° ¹æ¹ýÀÇ Çʿ伺
    • ¹ýÀÇÇÐ ¹× º¸¾È ÀÎÇÁ¶óÀÇ ÀÚ±Ý Á¶´Þ ¹× ±ÔÁ¦
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
    • ±â¹Ð µ¥ÀÌÅÍ Ãë±Þ¿¡ µû¸¥ À±¸®Àû, °³ÀÎÁ¤º¸ º¸È£ ¹®Á¦
  • ½ÃÀå ±âȸ
    • ÇöÀå °Ë»ç¿ë ¸ð¹ÙÀÏ À¯´Ö °³¹ß
    • ÀÇ·áÀÇ ¸ÂÃãÇü ÀÇ·á ¹× À¯ÀüÀÚ ¿¬±¸·ÎÀÇ Àû¿ë È®´ë
  • ½ÃÀå °úÁ¦
    • ±¹Á¦ ¹ý±Ô ¹× ±âÁØ Áؼö

Porter's Five Forces : °³ÀÎ ½Äº° ½ÃÀå Ž»öÀ» À§ÇÑ Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï »óȲÀ» ÀÌÇØÇÏ´Â µ¥ Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀïÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ¸ð»öÇϱâ À§ÇÑ ¸íÈ®ÇÑ ¹æ¹ýÀ» ¼³¸íÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» º¸¿ÏÇϰí, ÀáÀçÀû µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : °³ÀÎ ½Äº° ½ÃÀå¿¡¼­ÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº °³ÀÎ ½Äº° ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ ´ã°í ÀÖÀ¸¸ç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀ̰í Àû±ØÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : °³ÀÎ ½Äº° ½ÃÀå¿¡¼­ÀÇ °æÀï »óȲ ÆÄ¾Ç

°³ÀÎ ½Äº° ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ¼¼ºÐÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : °³ÀÎ ½Äº° ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÀÎü ÀÎ½Ä ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÒ ¼ö ÀÖ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î º¥´õ¸¦ Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : °³ÀÎ ½Äº° ½ÃÀå¿¡¼­ ¼º°øÀÇ ±æ ã±â

°³ÀÎ ½Äº° ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÎ¹®¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ½ÃÀå ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ±â¼úÇϰí ÀÖ½À´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, »ê¾÷ÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï »óȲÀ» öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ, ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº ¾îµðÀΰ¡?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õÀÇ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • DNA ¹è¿­ ºÐ¼®°ú »ýüÀÎ½Ä ±â¼ú Çõ½Å
      • ¹üÁË ¹ß»ý·ü »ó½Â¿¡ ÀÇÇØ °­·ÂÇÑ ½Å¿ø È®ÀÎ ¹æ¹ýÀÌ ÇÊ¿äÇÏ´Ù
      • ¹ýÀÇÇаú º¸¾È ÀÎÇÁ¶ó ÀÚ±Ý Á¶´Þ°ú ±ÔÁ¦
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
      • ±â¹Ð µ¥ÀÌÅÍ Ãë±ÞÀº À±¸®Àû ¹× ÇÁ¶óÀ̹ö½Ã ¹®Á¦¸¦ À¯¹ß
    • ±âȸ
      • ÇöÀå °Ë»ç¿ë À̵¿ À¯´Ö °³¹ß
      • ¸ÂÃãÇü ÀÇ·á¿Í À¯ÀüÀÚ Á¶»ç ÀÇ·á¿¡ ´ëÇÑ ÀÀ¿ë È®´ë
    • °úÁ¦
      • ±¹Á¦¹ý°ú ±âÁØ Áؼö
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
    • Á¦Ç° : Àΰ£ »ùÇÃÀ» Á¤È®ÇÏ°Ô ½Äº°Çϱâ À§ÇÑ ±â±âÀÇ Á߿伺
    • ¿ëµµ : ¹üÁ˸¦ ÇØ°áÇϱâ À§ÇÑ ¹ýÀÇÇÐÀÇ °³ÀÎ ½Äº° º¸±Þ
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå °³ÀÎ ½Äº° ½ÃÀå : Á¦Ç°º°

  • ¼Ò°³
  • ¼Ò¸ðǰ
    • DNA ÁõÆø ŰƮ¿Í ½Ã¾à
    • DNA ÃßÃâ ŰƮ¿Í ½Ã¾à
    • DNA Á¤·® ŰƮ¿Í ½Ã¾à
    • ½Å¼Ó DNA ¾î¼¼ÀÌ Å°Æ®¿Í ½Ã¾à
  • ±â±â
    • DNA ÁõÆø ½Ã½ºÅÛ
    • DNA ºÐ¼® ½Ã½ºÅÛ
    • DNA Á¤·® ½Ã½ºÅÛ
    • »ùÇà Á¶Á¦¿Í ÃßÃ⠽ýºÅÛ
  • ¼ÒÇÁÆ®¿þ¾î

Á¦7Àå °³ÀÎ ½Äº° ½ÃÀå : ±â¼úº°

  • ¼Ò°³
  • ¸ð¼¼°ü Àü±â¿µµ¿
  • ¸¶ÀÌÅ©·Î¾î·¹ÀÌ
  • Â÷¼¼´ë ½ÃÄö½Ì
  • ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ
  • ½Å¼Ó DNA ºÐ¼®

Á¦8Àå °³ÀÎ ½Äº° ½ÃÀå : ¿ëµµº°

  • ¼Ò°³
  • ¹ýÀÇÇÐ
  • Ä£ÀÚÈ®ÀÎ

Á¦9Àå °³ÀÎ ½Äº° ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼Ò°³
  • ¹ýÀÇÇÐ ¿¬±¸¼Ò
  • ¿¬±¸ ¼¾ÅÍ¿Í Çмú¡¤Á¤ºÎ±â°ü

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ °³ÀÎ ½Äº° ½ÃÀå

  • ¼Ò°³
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °³ÀÎ ½Äº° ½ÃÀå

  • ¼Ò°³
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °³ÀÎ ½Äº° ½ÃÀå

  • ¼Ò°³
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • Applied BioCode, ÷´Ü ¿¬±¸¿ë Çõ½ÅÀûÀÎ STI+ ³»¼º ÆÐ³ÎÀ» ¹ßÇ¥
    • ¹ÌÁ¦»ç°Ç ¼ö»ç¿¡ Çõ¸íÀ» ÀÏÀ¸Å°´Ù : QIAGENÀÇ ¹ýÀÇÇÐ Çõ½ÅÀ¸·Î °³ÀÎ ½Äº°ÀÇ »õ·Î¿î ±âÁØÀ» È®¸³
    • PromegaÀÇ PowerPlex 35GY ½Ã½ºÅÛÀ» ÅëÇÑ ¹ýÀÇÇÐ DNA ºÐ¼® Çõ¸í
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Abbott Laboratories
  • Abnova Corporation
  • Agilent Technologies,Inc.
  • ANDE Corporation
  • Autogen Inc.
  • Bio-Rad Laboratories, Inc.
  • Bioneer Corporation
  • BioTek Instruments, Inc.
  • Bode Cellmark Forensics, Inc. by Laboratory Corporation of America Holdings
  • Carl Zeiss AG
  • Carolina Biological Supply Company
  • Complete Genomics Incorporated
  • Eurofins Scientific SE
  • GE Healthcare
  • GENETEK BIOPHARMA GmbH
  • Hamilton Company
  • Illumina Inc.
  • Innogenomics Technologies LLC
  • LGC Limited
  • Ningbo HEALTH Gene Technology Co., Ltd.
  • Oxford Nanopore Technologies plc
  • PerkinElmer Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Softgenetics LLC
  • STRMIX LIMITED
  • Thermo Fisher Scientific Inc.
ksm 25.01.02

The Human Identification Market was valued at USD 769.45 million in 2023, expected to reach USD 841.01 million in 2024, and is projected to grow at a CAGR of 9.71%, to USD 1,472.89 million by 2030.

The scope and definition of human identification technologies encompass various methods that verify individual identities for security and business applications. This includes biometric systems like fingerprint recognition, iris and facial scanning, voice recognition, and DNA analysis. The necessity for these technologies arises from increasing concerns over security, identity fraud, and efficient processing in industries such as law enforcement, healthcare, banking, and border control. Human identification technologies find applications in access control, securing transactions, authentication processes, and providing personalized customer experiences, with end-use across governmental, commercial, and personal domains. Key factors influencing market growth include rapid advancements in machine learning, artificial intelligence, and identity management solutions that enhance accuracy, reduce costs, and improve user convenience. The increased adoption of mobile devices with integrated biometric systems and the rise in digitalization across sectors create substantial opportunities for market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 769.45 million
Estimated Year [2024] USD 841.01 million
Forecast Year [2030] USD 1,472.89 million
CAGR (%) 9.71%

Potential opportunities lie in the development of more robust multimodal identification systems that combine different biometric data to achieve higher accuracy and reduce spoofing risks. Developing regions present untapped markets with increasing demand for advanced identification platforms to bolster security measures. Recommendations to seize these opportunities include investing in R&D to innovate more secure yet cost-effective solutions, forming strategic partnerships for market entry, and focusing on compliance with privacy regulations to gain consumer trust. However, challenges such as high initial investment costs, privacy concerns, and the potential for technological obsolescence could impede market growth. Resistance from customers wary of privacy invasions and ethical concerns also pose challenges.

Innovation may thrive by focusing on enhancing the interoperability of systems across platforms and improving the robustness of identification technologies against complex real-world environments. Encouraging competitive pricing strategies and improving user experience can promote wider market adoption. The market is dynamic and competitive with numerous players striving for breakthroughs in technology, highlighting a need for continuous adaptation and agility to remain at the forefront.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Human Identification Market

The Human Identification Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Innovations in DNA sequencing and biometric technology
    • A higher incidence of crimes necessitates robust identification methods
    • Funding and regulations in forensic science and security infrastructure
  • Market Restraints
    • Handling sensitive data poses ethical and privacy issues
  • Market Opportunities
    • Development of mobile units for on-field testing
    • Expanding application in healthcare for personalized medicine and genetic research
  • Market Challenges
    • Compliance with international laws and standards

Porter's Five Forces: A Strategic Tool for Navigating the Human Identification Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Human Identification Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Human Identification Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Human Identification Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Human Identification Market

A detailed market share analysis in the Human Identification Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Human Identification Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Human Identification Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Human Identification Market

A strategic analysis of the Human Identification Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Human Identification Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abnova Corporation, Agilent Technologies,Inc., ANDE Corporation, Autogen Inc., Bio-Rad Laboratories, Inc., Bioneer Corporation, BioTek Instruments, Inc., Bode Cellmark Forensics, Inc. by Laboratory Corporation of America Holdings, Carl Zeiss AG, Carolina Biological Supply Company, Complete Genomics Incorporated, Eurofins Scientific SE, GE Healthcare, GENETEK BIOPHARMA GmbH, Hamilton Company, Illumina Inc., Innogenomics Technologies LLC, LGC Limited, Ningbo HEALTH Gene Technology Co., Ltd., Oxford Nanopore Technologies plc, PerkinElmer Inc., Promega Corporation, Qiagen N.V., Softgenetics LLC, STRMIX LIMITED, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Human Identification Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables, Instruments, and Software. The Consumables is further studied across DNA Amplification Kits & Reagents, DNA Extraction Kits & Reagents, DNA Quantification Kits & Reagents, and Rapid DNA Analysis Kits & Reagents. The Instruments is further studied across DNA Amplification Systems, DNA Analysis Systems, DNA Quantification Systems, and Sample Preparation & Extraction Systems.
  • Based on Technology, market is studied across Capillary Electrophoresis, Microarrays, Next-generation Sequencing, Polymerase Chain Reaction, and Rapid DNA Analysis.
  • Based on Application, market is studied across Forensics and Paternity Testing.
  • Based on End-User, market is studied across Forensic Laboratories and Research Centers and Academic & Government Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Innovations in DNA sequencing and biometric technology
      • 5.1.1.2. A higher incidence of crimes necessitates robust identification methods
      • 5.1.1.3. Funding and regulations in forensic science and security infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. Handling sensitive data poses ethical and privacy issues
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of mobile units for on-field testing
      • 5.1.3.2. Expanding application in healthcare for personalized medicine and genetic research
    • 5.1.4. Challenges
      • 5.1.4.1. Compliance with international laws and standards
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Essentiality of instruments in identifying human samples accurately
    • 5.2.2. Application: Proliferation of human identification in forensics to solve the crimes
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Human Identification Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. DNA Amplification Kits & Reagents
    • 6.2.2. DNA Extraction Kits & Reagents
    • 6.2.3. DNA Quantification Kits & Reagents
    • 6.2.4. Rapid DNA Analysis Kits & Reagents
  • 6.3. Instruments
    • 6.3.1. DNA Amplification Systems
    • 6.3.2. DNA Analysis Systems
    • 6.3.3. DNA Quantification Systems
    • 6.3.4. Sample Preparation & Extraction Systems
  • 6.4. Software

7. Human Identification Market, by Technology

  • 7.1. Introduction
  • 7.2. Capillary Electrophoresis
  • 7.3. Microarrays
  • 7.4. Next-generation Sequencing
  • 7.5. Polymerase Chain Reaction
  • 7.6. Rapid DNA Analysis

8. Human Identification Market, by Application

  • 8.1. Introduction
  • 8.2. Forensics
  • 8.3. Paternity Testing

9. Human Identification Market, by End-User

  • 9.1. Introduction
  • 9.2. Forensic Laboratories
  • 9.3. Research Centers and Academic & Government Institutes

10. Americas Human Identification Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Human Identification Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Human Identification Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Applied BioCode Unveils Innovative STI + Resistance Panel for Advanced Research Applications
    • 13.3.2. Revolutionizing Cold Case Investigations: QIAGEN's Forensic Innovations Set New Standards in Human Identification
    • 13.3.3. Revolutionizing Forensic DNA Analysis with Promega's PowerPlex 35GY System
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Abnova Corporation
  • 3. Agilent Technologies,Inc.
  • 4. ANDE Corporation
  • 5. Autogen Inc.
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Bioneer Corporation
  • 8. BioTek Instruments, Inc.
  • 9. Bode Cellmark Forensics, Inc. by Laboratory Corporation of America Holdings
  • 10. Carl Zeiss AG
  • 11. Carolina Biological Supply Company
  • 12. Complete Genomics Incorporated
  • 13. Eurofins Scientific SE
  • 14. GE Healthcare
  • 15. GENETEK BIOPHARMA GmbH
  • 16. Hamilton Company
  • 17. Illumina Inc.
  • 18. Innogenomics Technologies LLC
  • 19. LGC Limited
  • 20. Ningbo HEALTH Gene Technology Co., Ltd.
  • 21. Oxford Nanopore Technologies plc
  • 22. PerkinElmer Inc.
  • 23. Promega Corporation
  • 24. Qiagen N.V.
  • 25. Softgenetics LLC
  • 26. STRMIX LIMITED
  • 27. Thermo Fisher Scientific Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦